PrakashT. Cryptosporidiosis in a young male with systemic lupus erythematosus: a fatal case report. Trop Doct. Epub ahead of print 2025. DOI: 10.1177/00494755251403212.
2.
KunzlerALFTsokosGC. Infections in patients with systemic lupus erythematosus: the contribution of primary immune defects versus treatment-induced immunosuppression. Eur J Rheumatol2023; 10: 148–158.
3.
YipJAghdassiESuJ, et al.Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. J Rheumatol2010; 37: 1667–1672.
4.
WiedermannCJ. Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci2021; 22: 4496.
5.
HaqueIMitraKSircarG, et al.C1q monogenic lupus: a case series and review. Rheumatol Adv Pract2025; 9: rkaf064.
6.
AzarAAldaoudNHardenberghD, et al.Systemic lupus erythematosus and common variable immunodeficiency. J Clin Rheumatol2022; 28: E245–E248.
BassARChakravartyEAklEA, et al.2022 American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken)2023; 75: 449–464.
9.
WeiC-YYuH-HChengP-Y, et al.Increased susceptibility to salmonella infection in systemic lupus erythematosus compared with other systemic autoimmune diseases: insights from a retrospective cohort study from the largest health care system in Taiwan. Life2025; 15: 1522.
10.
LazarSKahlenbergJM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med2023; 74: 339–352.
11.
PredescuORVrejuFADinescuSC, et al.Vitamin D as an immune modulator in systemic lupus erythematosus: a narrative review. Life2025; 15: 1580.
12.
MarcoHSmithRMJonesRB, et al.The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease. BMC Musculoskelet Disord2014; 15: 178.
